DS Healthcare Group (DSKX)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated May 17, 2019 11:22 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
DS Healthcare Group, Inc. [DSKX]
Reports for Purchase
Showing records 1 - 20 ( 30 total )
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Terminating Coverage
Provider: Rodman & Renshaw, Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Future Direction Uncertain, Management Departures; Terminating Coverage
Provider: H.C. Wainwright & Co., Inc.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
After the Dust Settles, A Clear Path Forward; Reinstating Buy Rating, New Price Target $1.50
Provider: Rodman & Renshaw, Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
After the Dust Settles, A Clear Path Forward; Reinstating Buy Rating, New Price Target $1.50
Provider: H.C. Wainwright & Co., Inc.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Chairman Terminated, Accounting Adjustments Anticipated; Placing Our Rating and Price Target Under Review
Provider: Rodman & Renshaw, Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Chairman Terminated, Accounting Adjustments Anticipated; Placing Our Rating and Price Target Under Review
Provider: H.C. Wainwright & Co., Inc.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
New Acquisition Strategy Takes Shape; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
New Acquisition Strategy Takes Shape; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
DSKX Raises $5 Million To Boost Working Capital Ahead Of Debt Financing To Close Acquisition; Maintain BUY
Provider: Merriman Curhan Ford & Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Cruising Towards Closing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Cruising Towards Closing; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Shareholder Update Call Sets Expectation For 20% Sales Growth In DS Labs Product Lines In 2016
Provider: Merriman Curhan Ford & Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
3Q15 Results Reported: Looking Ahead to WR Group Acquisition; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
3Q15 Results Reported: Looking Ahead to WR Group Acquisition; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
3Q:15 OPEX Surge Offsets Double-Digit Sales Growth; Closure of WRG Deal Appears Imminent; Maintain BUY
Provider: Merriman Curhan Ford & Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Bringing in The Big Guns; DS Healthcare''s New CEO
Provider: H.C. Wainwright & Co., Inc.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Bringing in The Big Guns; DS Healthcare''s New CEO
Provider: Rodman & Renshaw, Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Attracts Seasoned CPG Industry Leader To Be CEO; Reiterate BUY, $5.00 Price Target
Provider: Merriman Curhan Ford & Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Initiate coverage with a BUY rating and a $5.00 price target
Provider: Merriman Curhan Ford & Co.
Company: DS Healthcare Group, Inc.
Industry: Cosmetics
Initiating at Buy with a $6.00 Price Target
Provider: Rodman & Renshaw, Co.